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Abstract
Background Mutations in the c-secretase enzyme subunits have been described in multiple kindreds with familial
hidradenitis suppurativa (HS).
Objective In this study, we report a novel nicastrin (NCSTN) mutation causing HS in a Dutch family. We sought to
explore the immunobiological function of NCSTNmutations using data of the Immunological Genome Project.
Methods Blood samples of three affected and two unaffected family members were collected. Whole-genome
sequencing was performed using genomic DNA isolated from peripheral blood leucocytes. Sanger sequencing was done
to conﬁrm the causative NCSTN variant and the familial segregation. The microarray data set of the Immunological Gen-
ome Project was used for thorough dissection of the expression and function of wildtype NCSTN in the immune system.
Results In a family consisting of 23 members, we found an autosomal dominant inheritance pattern of HS and
detected a novel splice site mutation (c.1912_1915delCAGT) in the NCSTN gene resulting in a frameshift and subse-
quent premature stop. All affected individuals had HS lesions on non-ﬂexural and atypical locations. Wildtype NCSTN
appears to be upregulated in myeloid cells like monocytes and macrophages, and in mesenchymal cells such as ﬁbrob-
lastic reticular cells and ﬁbroblasts. In addition, within the 25 highest co-expressed genes with NCSTN we identiﬁed
CAPNS1, ARNT and PPARD.
Conclusion This study reports the identiﬁcation a novel NCSTN gene splice site mutation which causes familial HS.
The associated immunobiological functions of NCSTN and its co-expressed genes ARNT and PPARD link genetics to
the most common environmental and metabolic HS risk factors which are smoking and obesity.
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Introduction
Hidradenitis suppurativa (HS), also known as acne inversa, is a
chronic, inflammatory and debilitating skin disease character-
ized by painful, deep-seated, inflammatory nodules and
abscesses, and in later stages sinus tract formation and scarring.
The characteristic lesions are mainly located in the inverse body
areas such as the axillary, inguinal and anogenital regions.1
The complex pathogenesis of HS starts with hyperplasia of the
follicular epithelium with infundibular hyperkeratosis and sub-
sequent follicular occlusion.2,3 The consequential dilatation of
the hair follicle results in a rupture with a foreign body-type
inflammatory immune response.4,5 In addition, multiple factors
are associated with the development and maintenance of the dis-
ease. Known environmental factors include smoking, obesity,
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mechanical friction and hormones, whereas endogenous factors
comprise female gender, an aberrant immunity and genetic pre-
disposition.6
A family history of HS is reported in up to 40% of
patients. A hereditary form of HS was first described in three
English families in 1984.7 However, a familial presentation
[MIM: 142690] displaying an autosomal dominant pattern of
inheritance with high penetrance is rare. The genetic basis of
this hereditary form of HS was first described in a Chinese
family in 2010 and involves heterozygous gene mutations in
the c-secretase subunits, which consists of presenilin (PSEN1
[MIM: 104311] and PSEN2 [MIM: 600759]), presenilin
enhancer 2 (PSENEN [MIM: 607632]), nicastrin (NCSTN
[MIM: 605254]) and anterior pharynx defective 1 (APH1A
[MIM: 607629] and APH1B [MIM: 607630]).8 To date, HS-
related mutations of the c-secretase genes have been identified
in 35 multiplex kindreds: 21 Chinese,4 French, 2 Japanese, 2
British, 2 Indian, 1 African American, 1 Iranian and 1 Jewish
Askenazi.9 Moreover, other genes have been associated with
syndromic HS. Most recently, a FGFR2 [MIM: 176943] mis-
sense mutation was found in one case displaying generalized
comedones, acne and HS.10 In addition, the PSTPIP1 gene
[MIM: 606347] has been implicated in patients with a syn-
dromic form of HS comprising HS, pyoderma gangrenosum,
acne and pyogenic arthritis (PASH/PAPASH).11 However, the
functional implications of the above-mentioned sequence vari-
ants remain unknown, and functional and proteomic studies
investigating the pathogenic mechanisms in familial HS are
currently scarce.11
In this study, we report a novel NCSTN mutation causing HS
in at least three generations of a Caucasian Dutch family, with
an autosomal dominant inheritance. We sought to explore the
immunobiological function of NCSTN mutations using the
Immunological Genome Project (ImmGen) data.
Material and Methods
Ethical statement
The research protocol was approved by the Institutional Review
Board of the Erasmus University Medical Center, Rotterdam
(reference NL45264.078.13). Written informed consent for the
diagnostic procedures including whole-genome sequencing was
obtained from all participants in accordance with the Declara-
tion of Helsinki.
The pedigree
A three-generation Caucasian family with HS was ascertained
via identification of the proband at the department of Dermatol-
ogy of the Erasmus University Medical Center in the Nether-
lands. The pedigree displayed an autosomal dominant
inheritance. The family consisted of three generations including
23 individuals, of which 10 were affected (60% male) and 13
were unaffected (Fig. 1). Blood samples of three affected (HS2A,
HS2C and HS3B) and two unaffected (HS1A, HS2B) individuals
were collected and genomic DNA was isolated from peripheral
blood leucocytes.
Whole-genome sequencing and validation analysis
Whole-genome sequencing was performed using the BGI’s
Complete Genomics platform as previously published.12
Sequence reads were mapped to the reference genome
(GRCh38), and variants were called by local de novo assembly
according to the methods previously described by Carnevali
et al.13 Analysis of the whole-genome sequencing data from all
sequenced family members was performed using Complete
Genomics Analysis tools, version 1.3.0, build 9 and TIBCO Spot-
fire software version 3.3.1. Mapped sequences of the five samples
varied between 132 and 146 Gb, resulting in an average coverage
between, respectively, 42- and 47-fold per genome. Subse-
quently, the pathogenic status of the identified sequence variants
was interpreted using Alamut. DNA flank primers were
designed to study DNA expression of the mutant allele on
peripheral blood leucocytes from all analysed individuals. Con-
firmation of the causative NCSTN variant and the familial segre-
gation were performed using Sanger sequencing.
Dissection of expression and function
The protein sequence of NCSTN exhibits multiple conserved
residues and is for 89% homologous to the murine counterpart.
Therefore, the microarray data set of the Immunological Gen-
ome Project (GSE15907)14–16 was used to perform a thorough
search for the expression and function of murine NCSTN in the
immune system. The expression data of the NCSTN gene were
normalized as part of the ImmGen pipeline by RMA as described
by Jojic et al.17 GEO sample (GSM) data were log2 transformed
and signatures for 16 lineages, both hematopoietic and mes-
enchymal, were subsequently calculated. Cut-off values of ≤
0.5 and ≥ 0.5 were applied on the Log2 scores in order to
HS1A
HS2A
HS2B HS2C
HS3B
p.S638fs
p.S638fs
p.S638fs
Figure 1 The pedigree is consistent with autosomal dominant
inheritance. Five individuals were investigated: HS2A (proband),
HS2C and HS3B were affected by a frameshift mutation
(p.S638 fs), while HS1A and HS2B were unaffected.
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select the most significant lineages. Stimulated cells were
excluded from the analysis as infectious mediators are not con-
sidered to be involved in the primary pathophysiology of HS.
Mast cells, basophilic granulocytes, dendritic precursor cells
(haematopoietic lineages), and adipocytes, osteocytes, chondro-
cytes, tenocytes and myocytes (mesenchymal lineages) are not
included in the GSE 15907 data set.
NCSTN-related transcripts
Using above-mentioned data set, we identified the 25 highest co-
expressed transcripts compared with wildtype NCSTN. Raw
intensity values of all samples were normalized by background
correction and quantile normalization using the V.6.4 Robust
Multichip Analysis (Partek Genomics Suite software, V.6.6; 2014
Partek Inc., St. Louis, Missouri, USA). The normalized data file
was transposed and imported into OmniViz V.6.1 (Instem) for
further analysis. Correlations with the expression of NCSTN
were calculated for all probes.
Results
Phenotype of affected individuals
The three-generation family comprised 23 individuals, of
which 10 were affected (60% male) and 13 were unaffected
(Fig. 1). Phenotyping of the individuals HS2A (proband),
HS2C and HS3B revealed a disease severity ranging from
mild to severe (Table 1). The proband displayed multiple,
interconnected, inflammatory lesions in the axillary, inguinal
and gluteal regions, resulting in a HS-PGA of 5 (very severe)
and significant impact on quality of life (DLQI = 17). The
perianal and perineal areas were affected for > 1% of the
total body surface area (BSA) consistent with a Hurley III
disease stage. In addition, multiple papules and cysts were
found in non-flexural and atypical locations including the
back, nape of the neck and the retro-auricular regions
(Fig. 2). In contrast, individuals HS2C and HS3B displayed
mild to moderate inflammatory activity (HS-PGA 2 to 3) and
low impact on quality of life (DLQI < 5) (Fig. S1 and S2).
HS onset before the age of twenty, the presence of follicular
lesions, and involvement of atypical locations such as the
head and neck region were found in all affected patients
(Table 1). Interestingly, HS2A (past smoker) and HS2C (cur-
rent smoker) suffered more severe disease than HS3B (non-
smoker). None of the affected patients was obese. Late-onset
Alzheimer’s disease within the pedigree was only reported in
the unaffected father of the proband.
NCSTN p.S638 fs mutation
The affected individuals were heterozygous, whereas the
healthy individuals demonstrated wildtype genotype. In total
8,479,202 variants were detected in one or more family
members, including single-nucleotide variants and small
insertions, deletions and substitutions (up to about 50 bp).
After filtering for heterozygous non-synonymous variants and
variants present in splice sites, seven variants were selected
(Table 2). None of these were present in the Wellderly data-
base (490 control samples sequenced by Complete Geno-
mics). The variant NCSTN c.1912_1915delCAGT had the
highest CADD score (35) and was not detected in any con-
trol data set (Exome Aggregation Consortium (ExAC),18
1000 Genomes Project,19 Wellderly Database, and Exome
Variant Server (EVS),20 NHLBI GO Exome Sequencing Pro-
ject (ESP), Seattle, WA (URL: http://evs.gs.washington.edu/
EVS/)). None of the other six gene mutations (MKRN1
[MIM: 607754], POTEA [MIM: 608915], EPS8 [MIM:
600206], RBBP6 [MIM: 600938], CDH19 [MIM: 603016],
PCNA [MIM: 176740]) could be directly linked to HS
pathophysiology. Moreover, the HGMD database licensed
through Qiagen/Biobase confirmed the previously identified
Table 1 Patient characteristics of the affected individuals (HS2A,
HS2C and HS3B).
HS2A
(proband)
HS2C HS3B
Age (years) 52 58 26
Gender Male Female Male
Age of HS onset (years) 18 16 16
Smoking status
[pack years]
past [36] positive
[26]
negative
Acne (history of) yes no no
Diabetes
mellitus (history of)
no no no
Hypertension (history of) no yes no
Abnormal lipid
proﬁle (history of)
no no no
Body Mass Index (kg/m2) 24.6 24.1 27.5
HS-PGA (0–5) 5 3 2
Modiﬁed Sartorius Score 191 19 10
Reﬁned Hurley stage52 III IIB IA
History of HS surgery yes yes no
Locations†
Flexural + + 
Non-ﬂexural + + +
Atypical + + +
Lesion types‡
Comedones  + 
Papules and folliculitis + + +
Cysts [location] + [neck/
auricular]
+ [neck/face] + [auricular]
NRS pain/itch (0–10) 4/5 0/0 0/0
DLQI (0–30) 17 4 0
†Flexural: armpit, groin, perianal/perineal, sub-mammary folds. Non-ﬂexural:
nape, back, buttocks. Atypical: face, limbs, abdomen, other.
‡Not including typical HS lesions (abscesses, nodules, sinuses).
DLQI, dermatology life quality index; HS-PGA, hidradenitis suppurativa –
physician global assessment scale; NRS, numerical rating scale.
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mutation in NCSTN to be causative in and associated with
familial HS.21 Results of the Sanger sequencing subsequently
confirmed the c.1912_1915delCAGT variant and the familial
segregation (Fig. S3). The CAGT deletion (p.S638) results in
a frameshift and premature termination codon. Protein
impact was visualized on structural data derived from NCBI
Homologene database and Protein Data Bank database and
compared with the amino acid sequence of other species
(Fig. 3). The C-terminal deletion present in the extracellular
(luminal) domain of the multiple alignment affects the tail
of the protein, resulting in loss of adherence with the mem-
brane structures (Fig. 4).
Figure 2 Phenotype of the proband with (1) overview of the right axilla with sinuses and scar contraction displaying Hurley stage II (2)
patient on left lateral recumbent with gluteal involvement displaying Hurley stage III, wound contractions after surgical excision, and HS
plaques in the upper leg (3) nodules/cysts (pencil marked) and atrophic scarring of the face and nape region, (4) overview of the scrotal,
inguinal area including HS plaque in the medial thigh, (5) detail of scarring and folliculitis on the back, (6) overview of the left axilla with
superﬁcial lesions displaying Hurley stage II.
Table 2 Summary of results of whole-genome sequencing after ﬁltering for heterozygous non-synonymous variants and variants present
in splice sites resulted in seven causal candidate sequence variants. The HGVS-nomenclature (versions 15.11) was used to describe
sequence variants53
# Gene Chr genomic DNA change (GRCh37) coding DNA change protein change mutation type CADD* SIFT
1 NCSTN 1 g.160326951_160326954del NM_001290186:c.1498_1501del, p.S500 fs Frameshift 35 Unknown
NM_015331:c.1912_1915del, p.S638 fs
NM_001290184:c.1852_1855del p.S618 fs
2 MKRN1 7 g.140154896C>G NM_013446:c.1235G>C p.R412P Missense 23.5 Tolerated
3 POTEA 8 g.43211968del NM_001002920:c.1149delG, p.E383 fs Frameshift 7.7 Unknown
NM_001005365:c.1287delG p.E429 fs
4 EPS8 12 g.15811097_15811098insAGAAAAC NM_004447:c.1027insGTTTTCT Unknown Unknown 3.7 Unknown
5 RBBP6 16 g.24581613C>T NM_018703:c.3500C>T, p.S1167F Missense 19.4 Deleterious
NM_006910:c.3602C>T p.S1201F
6 CDH19 18 g.64211217G>T NM_021153:c.1205C>A p.S402Y Missense 25.9 Deleterious
7 PCNA 20 g.5099501A>T NM_002592:c.233T>A p.I78K Missense 27.8 Deleterious
*CADD v1.3: Combined Annotation Dependent Depletion
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Expression and function of NCSTN and immune-related
transcripts
The dissection of the expression and function of NCSTN in the
immune system resulted in 681 unique lineages. The application
of the cut-off values resulted in 123 unique GSM samples, of
which 71 upregulated and 62 down-regulated. Nineteen of these
samples, n = 16 simulated cells and n = 3 microglia, were
excluded. A semi-quantitative analysis was performed on the
remaining 104 most significant samples to segregate both
hematopoietic and mesenchymal lineages. Each sample was cate-
gorized to one immunological cell class leading to a lineage-spe-
cific signature (Figs S4 and S5). Wildtype NCSTN appeared to
be upregulated in the myeloid cells: monocytes, macrophages,
non-lymphoid dendritic cells and to a lesser extent neutrophilic
granulocytes (Fig. S4. NCSTN also affected the mesenchymal
lineages by upregulation of fibroblastic reticular cells and fibrob-
lasts (Fig. S5). In addition, three genes of interest with similar
immunobiological function were identified among the 25 high-
est co-expressed genes: CAPNS1 [MIM: 114170], ARNT [MIM:
126110] and PPARD [MIM: 600409] of which the latter two are
most closely related to NCSTN, suggesting a common role in the
same pathway (Fig. 5).
Discussion
In this study, we report the identification of a novel NCSTN
gene splice site mutation, exon 16: c.1912_1915delCAGT, which
causes HS in a three-generation Dutch family. The affected
individuals of the pedigree were predominately men (male-
to-female ratio of 1.5:1), which is in accordance with literature
on familial HS describing a male-to-female ratio of 1.7:1.22–24 In
contrast, in common HS, women are generally more affected
than men with an associated male-to-female ratio of 1:3.25 In
addition, a history of acne with involvement of the back, the
presence of papules and cysts in non-flexural and atypical loca-
tions including the back, nape and auricular regions represent
the follicular phenotype, which characterize HS patients with
c-secretase mutations.24,26,27 Similarly, for a number of families
the genetic causes of HS are not yet identified as known gene
mutations were already excluded, suggesting that HS is most
likely a heterogeneous disease and additional genes may
contribute to the phenotype.
Compared to mutations in the other genes of the c-secretase
complex, sequence variants of the subunit NCSTN have been
most frequently reported in HS: 80% (28/35) in hereditary HS
and 90% (9/10) in individual cases of HS, indicating a critical
role for NCSTN in the stability of the c-secretase complex
(Table S1A,B).28 Most mutations in NCSTN cause a frameshift
and premature translation stop, potentially leading to impaired
activity of the c-secretase complex.
NCSTN acts to sterically block substrates with large ectodo-
mains, providing the mechanism by which c-secretase selectively
recruits ectodomain-shed substrates while also preventing cleav-
age of non-substrates.29 Over 90 transmembrane proteins have
been reported to be substrates of the c-secretase complex, and
Figure 3 Sequence alignment of NCSTN in human and other species. The amino acid sequence is given in the one-letter code. The
deleted serine (S; yellow) located in the C-terminus results in a frameshift. The altered sequence of mutated NCSTN (red) causes a prema-
ture stop (*). Conserved residues situated in the C-terminus are indicated in bold (S; N; F, Y and W). Identical amino acids in human and
murine are presented in grey boxes. WT: wildtype.
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the amyloid precursor protein (APP) and the Notch receptor are
two of the most widely known and studied substrates.30 APP
plays a central role in the development of Alzheimer’s disease,
while the Notch receptor regulates a variety of developmental
processes by controlling cell fate. Members of the Notch trans-
membrane protein family share multiple epidermal growth-like
factor (EGF) repeats in the ectodomain. In HS, it is hypothesized
that decreased Notch signalling causes a blockade of epidermal
cell differentiation resulting in follicular keratinization, ulti-
mately leading to cyst formation and a subsequent rupture fol-
lowed by an inflammatory response.31–33 However, proteomic
and functional studies investigating the impact of NCSTN muta-
tions on Notch signalling in HS are limited and have shown con-
tradictory results.32,34–36 A recent study demonstrated that
defective expression of NCSTN promotes keratinocytes prolifer-
ation via decreased miR-100-5p expression. More studies are
needed to investigate the role of miRNAs in HS patients with
NCSTN mutations.37
Our explorative analysis investigating the immunobiological
function of wildtype NCSTN revealed a myeloid and stromal
cell signature with upregulation in, respectively, monocytes,
macrophages, non-lymphoid dendritic cells, and fibroblasts
and fibroblastic reticular cells. We hypothesize that mutated
NCSTN could disturb the function of these cell lineages and
ultimately result in an aberrant immune response, especially
in the skin. In addition, three transcripts with similar
immunobiological function were identified within the 25
highest co-expressed genes related to NCSTN in the ImmGen
data. One of the genes was ARNT. The ARNT gene encodes
the aryl hydrocarbon receptor nuclear translocator protein
and forms a complex with the ligand-bound aryl hydrocar-
bon receptor (AhR).38 AhR is involved in the induction of
several enzymes that participate in xenobiotic metabolism
including dioxin and polycyclic aromatic hydrocarbons
(PAH) which are present in tobacco smoke. Hereby, AhR is
able to regulate immunological responses via B lymphocytes,
which are important in HS pathophysiology.39–41 The second
upregulated gene PPARD is a member of the nuclear-hor-
mone-receptor superfamily and governs a variety of biological
processes in peroxisomes. This gene enhances fatty acid
Figure 4 The gamma-secretase complex with wildtype nicastrin (purple), presinilin-1 (green), PEN-2 (blue) and APH-1 (orange). Mutated
NCSTN with the C-terminal deletion affects the tail of the protein resulting in a loss of interaction with the luminal and cytoplasmic mem-
brane. The left panel displays wildtype NCSTN. The right panel displays mutated NCSTN.
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catabolism through beta-oxidation, facilitates AhR signalling
and induces keratinocyte differentiation.42–44 Lastly, we iden-
tified CAPNS1, also known as CAPN4, which is a part of the
well-conserved family of calcium-dependent cysteine proteases
(Fig. 5). Calpain-like proteases process the precursor form of
IL-1a into the biologically active mature form, an important
pro-inflammatory cytokine in epithelial and myeloid cells.45,46
The importance of IL-1a was illustrated in one study, investi-
gating a human antibody targeting IL-1a, which showed
promising results in moderate to severe patients with HS
after 12 weeks of treatment.47
In addition to NCSTN, we found six other gene mutations,
none of which could be directly linked to HS pathophysiology.
However, the proteins encoded by PCNA, CDH19, ESP8 are
known to play a role in cell cycle, cytoskeletal signalling and
immunological responses. Mutations in these genes could mod-
ify cell proliferation and alter the innate immune response possi-
bly contributing to HS.48–50
A combination of careful delineation of the familial pheno-
type, together with functional analysis of NCSTN sequence vari-
ants and highly co-expressed genes are needed to gain a better
understanding of the underlying mechanisms in the pathophysi-
ology of both common and familial HS. Furthermore, larger
samples sizes are needed and international collaborations have
the potential to identify multiple familial cases with c-secretase
mutations.51 Ongoing efforts to elicit the functional conse-
quences of these mutations on gamma-secretase activity and
downstream signalling pathways have the potential to identify
novel therapeutic targets in this debilitating condition. We sug-
gest to search for (c-secretase) mutations when HS occurs in
both three consecutive generations and patients display follicular
lesions including involvement of atypical body sites such as the
head and neck.
This study reports a novel NCSTN gene splice site mutation,
exon 16: c.1912_1915delCAGT, in a three-generation Caucasian
family. Our explorative analysis demonstrates that the c-secre-
tase component NCSTN, which is the most frequently reported
sequence variant in familial HS, has a function in myeloid cells
and fibroblasts in the skin. In addition, the associated immuno-
biological functions of NCSTN, and it is co-expressed genes
ARNT and PPARD link genetics to well-known environmental
and metabolic triggers (smoking and obesity), both associated
with HS and disease severity.
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NCSTN:NM_001290186:exon13:c.1498_1501del:p.S500 fs
NCSTN:NM_015331:exon16:c.1912_1915del:p.S638 fs
NCSTN:NM_001290184:exon17:c.1852_1855del:p.S618 fs
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Supporting information
Additional Supporting Information may be found in the online
version of this article:
Table S1. A) c-secretase mutations found in familial HS,
updated on the 15th of August 2019. (B) c-secretase mutations
described in individual (sporadic) cases of HS.
Figure S1. Phenotype of HS2C with (1) right axilla including
scars and an inflammatory nodule (2) surgical scar after excision
of cyst (3) groins and pubic area displaying Hurley IIB with
moderate inflammation.
Figure S2. Phenotype of HS3B with (1) papules in the nape,
arrow indicating an auricular cyst (2) no disease activity in the
axillae (3) diffuse pattern of folliculitis in the gluteal area.
Figure S3. DNA sequence of the mutant allele (c.1912_1915del-
CAGT) and wildtype NCSTN. The CAGT bases are indicated in
the black box.
Figure S4. Wildtype NCSTN expression in hematopoietic cell
lineages display a myeloid signature with upregulation (red
color) in monocytes and macrophages. The colour intensity cor-
relates with the degree of change.
Figure S5. Mesenchymal cell lineages with wildtype NCSTN
RNA expression show upregulation of stromal cells and typically
FRC’s and fibroblasts. BEC: blood endothelial cell. LEC: lym-
phatic endothelial cell. FRC: fibroblastic reticular cell. The col-
our intensity correlates with the degree of RNA change.
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